Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Wino115


T.TH

RE:If it’s just $$ we need, then let’s go merge with one of the

Wait for TH1902 to get through Phase 1.  You'll know a whole lot...

November 17, 2021

T.TH

RE:RE:Another Target Expression Comparison: Trop-2

It is in the fourth section (Discussion) in their paper published in Cancer...

November 17, 2021

T.TH

RE:RE:RE:NASH collaboration

Took stock from 4-ish to 65-ish -- 15x your money.  Let us dream...

November 17, 2021

T.TH

RE:RE:RE:RE:Another Target Expression Comparison: Trop-2

Let's hope Dubuc or PL/Marsolais read this! I do think this would be the...

November 17, 2021

T.TH

RE:RE:Another Target Expression Comparison: Trop-2

I really think THTX would benefit it's shareholders by trying to put...

November 17, 2021

T.TH

RE:Another Target Expression Comparison: Trop-2

Wino115 wrote: So we learned from THTX that sortilin overexpression is 3x...

November 17, 2021

T.TH

Another Target Expression Comparison: Trop-2

So we learned from THTX that sortilin overexpression is 3x that of PD-1...

November 16, 2021

T.TH

RE:Trodelvy dose escalation trial results

Wonder what 1b showed? I haven't looked that up.  So 2/25 (8...

November 16, 2021

T.TH

RE:RE:RE:Soleus

Excellent point. I can't remember the details on who was prescient enough...

November 16, 2021

T.TH

RE:Soleus

The genesis of the firm is that they were the healthcare team for Paulson and...

November 16, 2021

T.TH

RE:Good News! - Soleus added 584,000 shares in Q3

This is reassuring news as they are certainly successful oncology investors. ...

November 15, 2021

T.TH

RE:RE:RE:So are we on to the next big thing?

From what I can see, the biotech oncology space is not all that different...

November 15, 2021

T.TH

RE:So are we on to the next big thing?

Not at all.  This is all about TH1902 suceeding, getting that high...

November 14, 2021

T.TH

RE:RE:"All the rage" Cancer Targets

Interesting, even if very far off.  What Paul said at the CS conf was...

November 14, 2021

T.TH

"All the rage" Cancer Targets

Been putting a bit of thought around this as I read so much about certain...

November 14, 2021

T.TH

RE:Patient Protocol Questions

First, which technique allowed you to get the picture in here?  I've...

November 13, 2021

T.TH

RE:RE:RE:RE:RE:My dream is

I believe you are correct, and without a doubt something brought in to the...

November 13, 2021

T.TH

RE:RE:RE:RE:RE:RE:My dream is

More than anything, I think this shows that Akero is now looked at as a...

November 13, 2021

T.TH

RE:RE:RE:My dream is

Completely agree, but as SPCEO often points out, the Wall St model is now...

November 12, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Credit Suisse event now available

All I would say is they did a huge shift from sales people to MSLs back when...

November 12, 2021

Featured Company